查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1971984

宠物基因检测套组市场：依宠物种类、检测类型、通路、技术及最终用户划分－2026年至2032年全球预测

Pet Genetic Test Kits Market by Pet Type, Test Type, Distribution Channel, Technology, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，宠物基因检测套组市场价值将达到 4.2639 亿美元，到 2026 年将成长至 4.7689 亿美元，到 2032 年将达到 8.5398 亿美元，年复合成长率为 10.43%。

主要市场统计数据
基准年 2025 4.2639亿美元
预计年份：2026年 4.7689亿美元
预测年份 2032 8.5398亿美元
复合年增长率 (%) 10.43%

全面介绍宠物基因检测套组市场的现状，基因组学、与临床实践的结合以及消费者需求都在共同作用，重塑着这个市场。

随着基因组学与伴侣动物照护的交叉领域不断拓展，宠物基因检测套组已从小众爱好发展成为饲主主人和兽医专业人士都能用来辅助日常决策的实用工具。检查室处理能力的提升、样本处理时间的缩短以及宠物饲主遗传学知识的普及，共同造就了更广阔的市场。同时，兽医专业人士也日益认识到基因资讯作为临床病史和影像诊断的补充，其价值在于能够实现早期疗育、制定个人化的健康管理方案，并做出更可靠的繁殖决策。

技术成熟、监管清晰以及饲主期望的改变正在推动整个测试组合和分销模式发生根本性过程。

宠物基因检测领域正经历着一场变革，其驱动力包括技术的成熟、消费者期望的不断变化以及临床对基因数据的接受度日益提高。高通量定序和先进的PCR技术的应用缩短了检测结果的返回时间，并拓宽了可检测突变的范围，使医疗机构能够更有信心地提供更丰富的资讯。同时，数位化平台透过将基因型与可操作的表型描述联繫起来，增强了结果的可解读性，将复杂的数据转化为可执行的护理建议。

该评估旨在评估近期关税调整对美国检测套组供应商的筹资策略、供应链韧性和营运风险的影响。

美国关税环境的变化为跨国供应链企业带来了新的挑战，尤其是那些从海外采购试剂、定序设备或成品检测套组的企业。关税调整会影响检查室耗材和硬体的投入成本，企业在权衡成本、前置作业时间和可靠性之间时，也可能需要调整供应商选择策略。为此，许多企业正在重新审视其采购体系，并探索近岸外包和其他替代采购方案，以维持利润率并稳定服务水准。

我们透过实际的細項分析来指导策略性投资决策，该分析整合了宠物种类、测试目的、通路、测试技术和最终用户需求。

精细的市场区隔分析清楚地展现了科学能力、临床需求和商业管道之间的交集。基于宠物品种的市场研究着重分析猫狗饲主动态特性和医疗需求的差异。犬类检测往往侧重于品种鑑定和遗传疾病筛检，而猫类检测则更侧重于特定疾病标记和性状分析。基于检测类型的分析涵盖了品种鑑定、遗传疾病筛检和性状分析等领域。每种检测类别都有其自身的检验要求、报告标准和临床应用案例，这些都会影响检查室的工作流程和消费者资讯的传播。基于通路的分析揭示了从线上零售、宠物商店到兽医诊所的整个生态系统，并指出了消费者在销售点教育、退货政策和检测后咨询方面的期望差异。

区域比较分析揭示了美洲、欧洲、中东和非洲以及亚太市场在需求、监管标准和流通结构的差异。

区域特征对需求推动要素、监管预期和通路结构有显着影响。在美洲，消费者对宠物保健产品表现出较高的熟悉度，对直接面向消费者（D2C）服务的需求强劲，同时兽医网络正在加强与诊断服务提供者的合作，并将基因资讯融入日常诊疗实践中。该地区还拥有密集的零售生态系统，专注于发展将检测、远端医疗和基因咨询相结合的附加价值服务。

公司如何透过科学严谨性、平台柔软性和策略合作伙伴关係脱颖而出，从而在宠物基因检测生态系统中建立值得信赖的地位。

宠物基因检测领域的竞争格局呈现出成熟诊断实验室、技术驱动新兴参与企业和专业细分领域企业之间的平衡。领先的实验室凭藉其深入的突变分析、认证资格和广泛的检验数据集脱颖而出，并以此为基础建立起临床医生的信任和机构合作关係。科技主导新兴参与企业则倾向于提昇平台灵活性、改进使用者介面以及垂直整合数位分析，将原始数据转化为对饲主和兽医的实际指南。专业细分领域企业则专注于特定疾病或品种，提供可靠的检测结果和专业的咨询服务，从而吸引知识渊博的消费者和繁殖者。

宠物基因检测市场的领导企业正在采取切实有效的策略措施，以提高临床可靠性、营运弹性和客户接受度。

产业领导者应优先采取一系列策略措施，在保持科学可信度的同时加速技术推广应用。首先，投资于解释框架和检验研究，以证明其在常见遗传疾病和影响分析中的临床效用。可靠的证据和同行评审的检验能够加强与兽医合作伙伴的关係，并减少临床引入过程中的阻力。其次，透过试剂来源多元化、评估近岸外包机会以及签订长期供应商协议来优化供应链，从而降低关税波动风险并维持服务水准。第三，设计整合清晰的检测前教育、针对饲主的具体检测后指导以及支持循证决策的高效临床医生介面的客户体验。

调查方法，详细介绍了多源整合、专家咨询和检验程序，以确保为决策者提供可靠、实用的见解。

本研究整合了已发表的文献、技术标准、专利趋势以及对检查室管理人员、执业兽医和产品负责人的专家访谈，建构了宠物基因检测领域的全貌。关键资料来源包括深入访谈，探讨检测检验方法、报告预期和通路经济效益；同时辅以一手和二手调查，以了解次世代定序(NGS) 和 PCR 平台的技术能力。调查方法强调证据三角验证，将来自从业人员的定性见解与对检测设计和监管指南的技术审查相结合，从而得出平衡的结论。

结论是，综合证据、健全的营运结构和以用户为中心的方法将决定宠物基因检测领域的长期成功。

实验室技术的进步、报告框架的完善以及饲主参与度的提高，正使宠物基因检测套组成为个人化宠物照护的策略基础。这些趋势为企业创造了机会，使其能够拓展临床效用、实现分销模式多元化，并透过附加价值服务深化客户关係。为了抓住这些机会，相关人员必须优先考虑检验、明确沟通管道并建立稳健的供应链，同时也需关注区域监管差异和不断变化的资料管治预期。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：以宠物类型分類的宠物基因检测套组市场

  • 猫
  • 狗

第九章：宠物基因检测套组市场（依检测类型划分）

  • 品种鑑定
  • 遗传疾病筛检
  • 特征分析

第十章：宠物基因检测套组市场：依分销管道划分

  • 线上零售
  • 宠物专卖店
  • 动物医院

第十一章 宠物基因检测套组市场：依技术划分

  • 次世代定序
  • PCR

第十二章 宠物基因检测套组市场：依最终用户划分

  • 宠物饲主
  • 研究机构
  • 兽医诊断检查室

第十三章 宠物基因检测套组市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 宠物基因检测套组市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 宠物基因检测套组市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国宠物基因检测套组市场

第十七章：中国宠物基因检测套组市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AlphaBiolabs Limited
  • Animal Genetics, Inc.
  • Basepaws, Inc.
  • DNA My Dog, LLC
  • Embark Veterinary, Inc.
  • GenSol Diagnostics, LLC
  • Mars, Incorporated
  • Neogen Corporation
  • Orivet Innovations Pty Ltd
  • Paw Print Genetics, LLC
  • PetDx, Inc.
  • Prenetics Global Limited
Product Code: MRR-2B5802CFEA36

The Pet Genetic Test Kits Market was valued at USD 426.39 million in 2025 and is projected to grow to USD 476.89 million in 2026, with a CAGR of 10.43%, reaching USD 853.98 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 426.39 million
Estimated Year [2026] USD 476.89 million
Forecast Year [2032] USD 853.98 million
CAGR (%) 10.43%

A comprehensive primer on how genomics, clinical practice integration, and consumer demand are collectively reshaping the pet genetic test kit landscape

The expanding intersection of genomics and companion animal care has elevated pet genetic test kits from niche curiosities to practical tools that inform day-to-day decisions for owners and practitioners alike. Advances in laboratory throughput, reductions in per-sample processing time, and the mainstreaming of genetic literacy among pet owners have all contributed to a more receptive market. In parallel, veterinary professionals are increasingly recognizing genetic information as complementary to clinical history and diagnostic imaging, enabling earlier intervention, bespoke wellness plans, and more confident breeding decisions.

Moreover, the maturation of direct-to-consumer models has lowered barriers to access while simultaneously raising expectations for clarity, clinical relevance, and data security. This dynamic has driven platform providers to refine reporting, improve variant interpretation frameworks, and strengthen user experience. As technologies evolve, test portfolios continue to broaden, moving beyond single-gene assays to multi-gene panels and more comprehensive trait analyses. Taken together, these shifts position pet genetic test kits as a consequential element of modern pet care, attractive to owners seeking personalized insights and to practitioners who aim to integrate genomic data into evidence-based practice.

How technological maturation, evolving regulatory clarity, and shifting owner expectations are driving decisive transformations across testing portfolios and distribution models

The landscape for pet genetic testing is undergoing transformative shifts driven by technological maturation, evolving consumer expectations, and an expanding clinical acceptance of genetic data. High-throughput sequencing and refined PCR applications have reduced turnaround times and increased the breadth of detectable variants, enabling providers to deliver richer insights with improved confidence. At the same time, digital platforms are enhancing the interpretability of results by linking genotype to actionable phenotype narratives, thereby translating complex data into practical care recommendations.

Concurrently, the regulatory conversation around genetic testing for companion animals is gaining clarity in many jurisdictions, prompting providers to elevate their clinical validation standards and transparency practices. Consumer behavior has shifted toward proactive health management for pets, and this is reflected in growing interest for preventive genetic screens and trait analyses that inform nutrition, exercise, and monitoring strategies. Partnerships across veterinary networks, diagnostic labs, and retail channels are becoming more strategic, enabling broader distribution while preserving clinical integrity. These interlocking developments are creating a market environment in which speed, evidence-backed interpretation, and trustworthiness become decisive competitive differentiators.

Assessing how recent tariff adjustments are reshaping procurement strategies, supply-chain resilience, and operational risk for test kit providers in the United States

The evolving tariff landscape in the United States has introduced additional considerations for companies operating across international supply chains, particularly where reagents, sequencing instruments, or finished testing kits are procured from abroad. Tariff adjustments can influence input costs for lab consumables and hardware, and they may also alter supplier selection strategies as firms assess the trade-offs between cost, lead time, and reliability. In response, many operators reassess procurement footprints, exploring nearshoring and alternative sourcing to preserve margin and maintain consistent service levels.

Beyond procurement, tariffs can incentivize vertical integration strategies where larger providers absorb more elements of production to mitigate exposure to cross-border duties. Smaller laboratories and direct-to-consumer vendors may seek long-term supply contracts or engage in collaborative purchasing arrangements to stabilize prices. Importantly, program managers must also consider the indirect effects of tariffs on partner ecosystems, including distributors and veterinary clinics, since increased costs can cascade through channel economics and reshape pricing structures. Ultimately, tariff volatility underscores the need for dynamic sourcing models, scenario planning, and cost-control measures to ensure resilient operations.

Actionable segmentation insights that align pet type, testing purpose, distribution pathways, laboratory technology, and end-user needs to guide strategic investment decisions

A nuanced view of segmentation provides clarity on where scientific capability, clinical demand, and commercial channels intersect. Based on Pet Type, market study focuses on distinct owner behaviors and medical needs for Cat and Dog populations, with canine testing typically reflecting higher demand for breed identification and inherited condition screening while feline testing emphasizes specific disease markers and trait characterization. Based on Test Type, the landscape spans Breed Identification, Genetic Disease Screening, and Trait Analysis; each test category has unique validation requirements, reporting conventions, and clinical use-cases that influence lab workflows and consumer messaging. Based on Distribution Channel, the ecosystem extends through Online Retail, Pet Specialty Stores, and Veterinary Clinics, creating divergent expectations around point-of-sale education, return policies, and post-test counseling.

Furthermore, Based on Technology, providers adopt either Next Generation Sequencing or PCR platforms; sequencing affords broader variant detection and scalability for panel expansion, whereas PCR delivers rapid, cost-effective assays for targeted markers and high-throughput screening. Based on End User, segmentation differentiates Pet Owners, Research Institutions, and Veterinary Diagnostics Labs, each with distinct requirements for data granularity, reporting formats, and regulatory compliance. Integrating these segmentation lenses reveals clear priority areas for product development, customer experience design, and partnership models, and it also illuminates where technical investment will deliver the greatest incremental value across customer cohorts.

Comparative regional insights that illuminate how demand, regulatory norms, and channel structures differ across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics shape demand drivers, regulatory expectations, and channel structures in meaningful ways. In the Americas, consumers display high familiarity with pet wellness products and a strong appetite for direct-to-consumer offerings, while veterinary networks increasingly partner with diagnostic providers to integrate genetic information into routine care. This region also features dense retail ecosystems and an emphasis on value-added services that bundle testing with telemedicine or genetic counseling.

In Europe, Middle East & Africa, the regulatory environment and clinical practice norms vary substantially across countries, leading companies to adopt differentiated go-to-market strategies; in some markets, stringent regulatory standards and a conservative clinical culture prioritize validated assays and veterinary-mediated distribution, whereas emerging markets within the region present opportunities for education-led adoption and tiered pricing models. Across Asia-Pacific, growth is shaped by rapid digital adoption, expanding pet ownership, and a mix of sophisticated urban markets alongside cost-sensitive segments; providers often navigate complex logistics and localization requirements, including language, reporting templates, and alignment with local veterinary protocols. Recognizing these regional contrasts allows firms to calibrate product portfolios, compliance investments, and channel partnerships to local market expectations while maintaining coherent global standards of quality and interpretation.

How companies are differentiating through scientific rigor, platform agility, and strategic partnerships to establish trusted positions in the pet genetic testing ecosystem

Competitive dynamics in the pet genetic testing space reflect a balance between established diagnostic laboratories, technology-focused entrants, and niche specialists. Leading laboratories differentiate themselves through depth of variant curation, accreditation credentials, and extensive validation datasets, which together underpin clinician trust and institutional partnerships. Technology-driven entrants tend to emphasize platform agility, improved user interfaces, and vertical integration of digital analytics to convert raw data into actionable guidance for owners and practitioners. Niche specialists often focus on a narrow set of conditions or breed groups, offering high-confidence results and domain-specific counseling that appeals to informed consumers and breeders.

Strategic collaborations among companies, veterinary networks, and research centers are common, enabling the sharing of variant evidence and the co-development of validated panels. Companies that prioritize transparent variant interpretation, invest in clinician education, and offer flexible delivery through both retail and clinical channels generally secure stronger adoption. As privacy and data governance become more central to stakeholder expectations, firms that implement rigorous consent frameworks and clear data-use policies gain a reputational advantage. The most resilient competitors combine scientific rigor with accessible reporting and robust channel relationships, positioning themselves to capture both clinical and consumer demand streams.

Practical, high-impact strategic steps for market leaders to enhance clinical credibility, operational resilience, and customer adoption in pet genetic testing

Industry leaders should prioritize a set of strategic moves that accelerate adoption while safeguarding scientific credibility. First, invest in interpretive frameworks and validation studies that demonstrate clinical utility for common inherited conditions and high-impact trait analyses; robust evidence and peer-reviewed validation will strengthen relationships with veterinary partners and reduce friction in clinical adoption. Second, optimize supply chains by diversifying reagent sourcing, evaluating nearshoring opportunities, and establishing long-term supplier agreements to buffer against tariff-related volatility and to sustain service levels. Third, design customer journeys that integrate clear pre-test education, actionable post-test guidance for owners, and streamlined clinician interfaces to support evidence-based decision-making.

Moreover, consider modular product strategies that allow clients to scale from single-marker PCR tests to broader sequencing-based panels as needs evolve, thereby lowering the barrier to entry while preserving upgrade pathways. Strengthen data governance practices by instituting transparent consent mechanisms, privacy-preserving data architectures, and clear policies on secondary research uses, which together build consumer trust and align with emerging regulatory expectations. Finally, pursue selective partnerships with veterinary networks, research institutions, and specialty retailers to extend reach while ensuring consistent messaging and clinical oversight; these relationships can also support longitudinal data collection that enhances variant interpretation over time.

Methodology detailing the multi-source synthesis, expert consultations, and validation steps used to ensure robust, actionable insights for decision-makers

This research synthesizes publicly available literature, technical standards, patent landscapes, and expert interviews with laboratory directors, practicing veterinarians, and product leaders to construct a comprehensive view of the pet genetic testing domain. Primary inputs included in-depth interviews that explored assay validation practices, reporting expectations, and channel economics, complemented by secondary research that mapped technological capabilities across Next Generation Sequencing and PCR platforms. The methodology emphasizes triangulation of evidence, combining qualitative insights from practitioners with technical reviews of assay architectures and regulatory guidance to ensure balanced conclusions.

Analytical steps included cross-segmentation comparisons to identify where technology choice, end-user needs, and distribution channels intersect, followed by scenario planning to assess the operational implications of tariff shifts and supply-chain disruptions. Quality control measures comprised source verification, stakeholder corroboration, and sensitivity checks on key assumptions underlying strategic recommendations. Where gaps in public evidence existed, targeted expert consultations filled information voids, and all interpretive statements were grounded in consensus perspectives or documented technical rationale. Transparency in the research approach enables readers to understand the provenance of insights and to apply them appropriately within their own operational contexts.

Concluding perspectives on how integrated evidence, resilient operations, and user-centric delivery will determine long-term success in the pet genetic testing arena

The convergence of improved laboratory technologies, more sophisticated reporting frameworks, and heightened owner engagement is positioning pet genetic test kits as a strategic enabler of personalized pet care. Together, these trends create opportunities for companies to expand clinical utility, diversify distribution models, and deepen customer relationships through value-added services. To realize these opportunities, stakeholders must prioritize validation, clarity of communication, and resilient supply chains, while remaining attentive to regional regulatory differences and evolving data governance expectations.

As the field matures, the most successful organizations will be those that combine scientific excellence with user-centric design and strong channel partnerships. They will invest in evidence that links genetic findings to actionable care pathways, streamline access through multiple distribution touchpoints, and maintain transparent policies that build trust in long-term data stewardship. Ultimately, genetic testing is most valuable when it complements clinical judgment and empowers owners with information that can meaningfully improve health outcomes and strengthen the human-animal bond.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pet Genetic Test Kits Market, by Pet Type

  • 8.1. Cat
  • 8.2. Dog

9. Pet Genetic Test Kits Market, by Test Type

  • 9.1. Breed Identification
  • 9.2. Genetic Disease Screening
  • 9.3. Trait Analysis

10. Pet Genetic Test Kits Market, by Distribution Channel

  • 10.1. Online Retail
  • 10.2. Pet Specialty Stores
  • 10.3. Veterinary Clinics

11. Pet Genetic Test Kits Market, by Technology

  • 11.1. Next Generation Sequencing
  • 11.2. Pcr

12. Pet Genetic Test Kits Market, by End User

  • 12.1. Pet Owners
  • 12.2. Research Institutions
  • 12.3. Veterinary Diagnostics Labs

13. Pet Genetic Test Kits Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pet Genetic Test Kits Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pet Genetic Test Kits Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pet Genetic Test Kits Market

17. China Pet Genetic Test Kits Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AlphaBiolabs Limited
  • 18.6. Animal Genetics, Inc.
  • 18.7. Basepaws, Inc.
  • 18.8. DNA My Dog, LLC
  • 18.9. Embark Veterinary, Inc.
  • 18.10. GenSol Diagnostics, LLC
  • 18.11. Mars, Incorporated
  • 18.12. Neogen Corporation
  • 18.13. Orivet Innovations Pty Ltd
  • 18.14. Paw Print Genetics, LLC
  • 18.15. PetDx, Inc.
  • 18.16. Prenetics Global Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PET GENETIC TEST KITS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PET GENETIC TEST KITS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY CAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY CAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY CAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY DOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY DOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY DOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY BREED IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY BREED IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY BREED IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TRAIT ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TRAIT ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TRAIT ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET OWNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY DIAGNOSTICS LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY DIAGNOSTICS LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY VETERINARY DIAGNOSTICS LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. GCC PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. GCC PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. GCC PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. GCC PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. G7 PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. G7 PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. G7 PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. G7 PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. NATO PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NATO PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. NATO PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. NATO PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PET GENETIC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA PET GENETIC TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA PET GENETIC TEST KITS MARKET SIZE, BY PET TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA PET GENETIC TEST KITS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA PET GENETIC TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA PET GENETIC TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA PET GENETIC TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)